Ke Li
发表
Guoqiang Dong,
C. Sheng,
Tiantian Wang,
2013,
Journal of medicinal chemistry.
Qisheng Li,
Zhiliang Lv,
Mingfeng Zhang,
2013,
European journal of medicinal chemistry.
Wannian Zhang,
Zhiliang Lv,
Mingfeng Zhang,
2012
.
Zhiliang Lv,
Mingfeng Zhang,
Ke Li,
2013
.
Zhen-liang Sun,
Huan Chen,
Zhiliang Lv,
2013,
European journal of medicinal chemistry.
Jilu Feng,
C. Sheng,
Tiantian Wang,
2010,
Journal of medicinal chemistry.
Jilu Feng,
C. Sheng,
Tiantian Wang,
2010,
Bioorganic & Medicinal Chemistry Letters.
Tiantian Wang,
Huan Chen,
Yongmei Li,
2011,
Bioorganic & medicinal chemistry letters.
Zhiliang Lv,
Chunjuan Niu,
Ke Li,
2010
.
Zhiliang Lv,
Mingfeng Zhang,
Ke Li,
2014
.
Ke Li,
Chao-mei Liu,
Yong-bing Cao,
2007
.
Tiantian Wang,
Mingfeng Zhang,
Dongping Geng,
2012,
European journal of medicinal chemistry.
Tiantian Wang,
Huan Chen,
Zhiliang Lv,
2011
.
Ke Li,
Cheng-Mang Liu,
Q. Zheng,
2018
.
Yongmei Li,
Zhiliang Lv,
Mingfeng Zhang,
2012,
European journal of medicinal chemistry.
Tie-jun Li,
Zhengxue Quan,
Huanhuan Dong,
2010
.
Y. Li,
Zhiliang Lv,
Dongping Geng,
2010,
Bioorganic & Medicinal Chemistry Letters.
Y. Li,
Zhiliang Lv,
Dongping Geng,
2010
.
Jilu Feng,
Tiantian Wang,
Zhiliang Lv,
2009
.
Identification of Novel, Potent, and Orally Available GCN2 Inhibitors with Type I Half Binding Mode.
M. Klein,
R. Tjhen,
Biching Sang,
2019,
ACS medicinal chemistry letters.